EU Project Takes ACTION with Bio, Grid and Nano Technology Development

European researchers have forged a partnership with counterparts in the Western Balkans, North Africa and Latin America to strengthen cooperation in the fields of biomedical informatics (BMI), grid technologies and nanoinformatics. Their work is being carried out through ACTION-Grid, a project supported by the EU's Seventh Framework Programme (FP7) with funding totalling some €1 million. ACTION-Grid kicked off in June and will run for a period of 18 months.

The ACTION-Grid consortium aims to maximise the potential of biomedical data and computing resources. The project partners' work effectively reinforces the European Commission's position that research groups improve their understanding of activities carried out in target countries such as those from the Western Balkans and Latin America. The partners will focus on finding and fuelling cooperation, as well as identifying viable activities for the future. Besides establishing a collaborative environment between the regions, the seven-member consortium will exchange research results and contribute to improving the EU's Research Programme in a specific area.

Their work will develop training and mobility in BMI, grid and nanoinformatics. The consortium says the results will be integrated with data from an automated 'resourceome', an inventory of BMI/grid/nano methods and services developed by the ACTION-Grid team. This inventory can be accessed by researchers and users. Ultimately, the resourceome will enable researchers - from the across the board - to access the new technologies developed in the EU.

With support from a panel of recognised experts, the consortium will also develop a White Paper, which will be presented to the EC so as to initiate new plans in the regions in question.

The dissemination of the ACTION-Grid results will be made possible via an international symposium on BMI and grid, as well as scientific publications, newsletters, press releases and a website.

The upshot of the ACTION-Grid project is that major achievements in the fields of BMI and grid computing, including tools, expertise and methods, can be reused and transferred to the Western Balkans, North Africa and Latin America. The knowledge gained in ACTION-Grid will also be incurred from key successes achieved by the consortium in the past. Examples include past EU-backed GRID-based projects, including Gripps, MediGrid, GLOP and eDiamond.

The EU has been relentless in its pursuit over the last 10 years to establish and implement initiatives linking clinical data and results from a myriad of projects, methods and tools in the BMI area. It should be noted that EU research in the areas of genomic and personalised medicine has encouraged scientists to participate in the various research projects that have got off the ground in the region.

Specifically, the link between ACTION-Grid and the field of medicine is nanoinformatics; ACTION-Grid is the EU's maiden project targeting the development of this discipline. The consortium says nanomedicine has the capacity to meliorate existing diagnostic methods and treatments.

Coordinated by the Biomedical Informatics Group at the Madrid Polytechnic University in Spain, ACTION-Grid brings together partners from Argentina, Chile, Croatia, France and Greece.

For further information, please visit:
http://www.action-grid.eu/

Related article:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...